It has been over one year that Dr Chan has been ta

It has been over one year that Dr Chan has been taking Leronlimab, and fighting Glioblastoma Wild Type. Dr Chan's last MRI showed that the tumor has regressed in some areas, and has grown slightly in other areas. His Oncologist still has him on steroids, so he is overweight. His mobility is limited. At times he has to rely on a either a scooter or other ambulatory help. He says that, at times, he just wants to get up and walk over to his wife and his legs will just not cooperate. Still, he is attending concerts, and other events. He is spending quality time with family and friends. He looks good in recent pictures and has shown good energy. I can't help but feel he owes his quality of life to Leronlimab, and the love and support of his family and friends. If you figure that Leronlimab is at 80% receptor occupancy, north of the blood brain barrier, plus it's mechanism of action is further weakened by the steroids, it's contribution to improving his strength and keeping side effects (from other treatments) to a minimum is priceless.
I hope our guys are getting enough information, to be able to optimize dosage and treatment for better receptor occupancy, and better effect against the cancer. In Dr Chan's case, Leronlimab seems to work excellent as a adjuvant therapy. It would be nice to see it optimized to become the primary therapy.